These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 27075013)

  • 1. A detailed clinical analysis of 13 patients with AUTS2 syndrome further delineates the phenotypic spectrum and underscores the behavioural phenotype.
    Beunders G; van de Kamp J; Vasudevan P; Morton J; Smets K; Kleefstra T; de Munnik SA; Schuurs-Hoeijmakers J; Ceulemans B; Zollino M; Hoffjan S; Wieczorek S; So J; Mercer L; Walker T; Velsher L; ; Parker MJ; Magee AC; Elffers B; Kooy RF; Yntema HG; Meijers-Heijboer EJ; Sistermans EA
    J Med Genet; 2016 Aug; 53(8):523-32. PubMed ID: 27075013
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Two male adults with pathogenic AUTS2 variants, including a two-base pair deletion, further delineate the AUTS2 syndrome.
    Beunders G; de Munnik SA; Van der Aa N; Ceulemans B; Voorhoeve E; Groffen AJ; Nillesen WM; Meijers-Heijboer EJ; Frank Kooy R; Yntema HG; Sistermans EA
    Eur J Hum Genet; 2015 Jun; 23(6):803-7. PubMed ID: 25205402
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exonic deletions in AUTS2 cause a syndromic form of intellectual disability and suggest a critical role for the C terminus.
    Beunders G; Voorhoeve E; Golzio C; Pardo LM; Rosenfeld JA; Talkowski ME; Simonic I; Lionel AC; Vergult S; Pyatt RE; van de Kamp J; Nieuwint A; Weiss MM; Rizzu P; Verwer LE; van Spaendonk RM; Shen Y; Wu BL; Yu T; Yu Y; Chiang C; Gusella JF; Lindgren AM; Morton CC; van Binsbergen E; Bulk S; van Rossem E; Vanakker O; Armstrong R; Park SM; Greenhalgh L; Maye U; Neill NJ; Abbott KM; Sell S; Ladda R; Farber DM; Bader PI; Cushing T; Drautz JM; Konczal L; Nash P; de Los Reyes E; Carter MT; Hopkins E; Marshall CR; Osborne LR; Gripp KW; Thrush DL; Hashimoto S; Gastier-Foster JM; Astbury C; Ylstra B; Meijers-Heijboer H; Posthuma D; Menten B; Mortier G; Scherer SW; Eichler EE; Girirajan S; Katsanis N; Groffen AJ; Sistermans EA
    Am J Hum Genet; 2013 Feb; 92(2):210-20. PubMed ID: 23332918
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Attention Deficit Hyperactivity and Autism Spectrum Disorders as the Core Symptoms of AUTS2 Syndrome: Description of Five New Patients and Update of the Frequency of Manifestations and Genotype-Phenotype Correlation.
    Sanchez-Jimeno C; Blanco-Kelly F; López-Grondona F; Losada-Del Pozo R; Moreno B; Rodrigo-Moreno M; Martinez-Cayuelas E; Riveiro-Alvarez R; Fenollar-Cortés M; Ayuso C; Rodríguez de Alba M; Lorda-Sanchez I; Almoguera B
    Genes (Basel); 2021 Aug; 12(9):. PubMed ID: 34573342
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Germ cell mosaicism for AUTS2 exon 6 deletion.
    Gieldon L; Jauch A; Obeid K; Kaufmann L; Hinderhofer K; Haug U; Moog U
    Am J Med Genet A; 2021 Apr; 185(4):1261-1265. PubMed ID: 33577136
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exonic deletions of AUTS2 in Chinese patients with developmental delay and intellectual disability.
    Fan Y; Qiu W; Wang L; Gu X; Yu Y
    Am J Med Genet A; 2016 Feb; 170A(2):515-522. PubMed ID: 26545289
    [TBL] [Abstract][Full Text] [Related]  

  • 7. De novo single exon deletion of AUTS2 in a patient with speech and language disorder: a review of disrupted AUTS2 and further evidence for its role in neurodevelopmental disorders.
    Amarillo IE; Li WL; Li X; Vilain E; Kantarci S
    Am J Med Genet A; 2014 Apr; 164A(4):958-65. PubMed ID: 24459036
    [TBL] [Abstract][Full Text] [Related]  

  • 8. De novo small deletion affecting transcription start site of short isoform of AUTS2 gene in a patient with syndromic neurodevelopmental defects.
    Martinez-Delgado B; Lopez-Martin E; Lara-Herguedas J; Monzon S; Cuesta I; Juliá M; Aquino V; Rodriguez-Martin C; Damian A; Gonzalo I; Gomez-Mariano G; Baladron B; Cazorla R; Iglesias G; Roman E; Ros P; Tutor P; Mellor S; Jimenez C; Cabrejas MJ; Gonzalez-Vioque E; Alonso J; Bermejo-Sánchez E; Posada M
    Am J Med Genet A; 2021 Mar; 185(3):877-883. PubMed ID: 33346930
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Confirmation of chromosomal microarray as a first-tier clinical diagnostic test for individuals with developmental delay, intellectual disability, autism spectrum disorders and dysmorphic features.
    Battaglia A; Doccini V; Bernardini L; Novelli A; Loddo S; Capalbo A; Filippi T; Carey JC
    Eur J Paediatr Neurol; 2013 Nov; 17(6):589-99. PubMed ID: 23711909
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phenotypic and molecular insights into CASK-related disorders in males.
    Moog U; Bierhals T; Brand K; Bautsch J; Biskup S; Brune T; Denecke J; de Die-Smulders CE; Evers C; Hempel M; Henneke M; Yntema H; Menten B; Pietz J; Pfundt R; Schmidtke J; Steinemann D; Stumpel CT; Van Maldergem L; Kutsche K
    Orphanet J Rare Dis; 2015 Apr; 10():44. PubMed ID: 25886057
    [TBL] [Abstract][Full Text] [Related]  

  • 11. AUTS2 Syndrome in a 68-year-old female: Natural history and further delineation of the phenotype.
    Sengun E; Yararbas K; Kasakyan S; Alanay Y
    Am J Med Genet A; 2016 Dec; 170(12):3231-3236. PubMed ID: 27531620
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Whole Exome Sequencing Reveals a Novel
    Palumbo P; Di Muro E; Accadia M; Benvenuto M; Di Giacomo MC; Castellana S; Mazza T; Castori M; Palumbo O; Carella M
    Genes (Basel); 2021 Feb; 12(2):. PubMed ID: 33562463
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The DYRK1A gene is a cause of syndromic intellectual disability with severe microcephaly and epilepsy.
    Courcet JB; Faivre L; Malzac P; Masurel-Paulet A; Lopez E; Callier P; Lambert L; Lemesle M; Thevenon J; Gigot N; Duplomb L; Ragon C; Marle N; Mosca-Boidron AL; Huet F; Philippe C; Moncla A; Thauvin-Robinet C
    J Med Genet; 2012 Dec; 49(12):731-6. PubMed ID: 23099646
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ten new cases further delineate the syndromic intellectual disability phenotype caused by mutations in DYRK1A.
    Bronicki LM; Redin C; Drunat S; Piton A; Lyons M; Passemard S; Baumann C; Faivre L; Thevenon J; Rivière JB; Isidor B; Gan G; Francannet C; Willems M; Gunel M; Jones JR; Gleeson JG; Mandel JL; Stevenson RE; Friez MJ; Aylsworth AS
    Eur J Hum Genet; 2015 Nov; 23(11):1482-7. PubMed ID: 25920557
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Haploinsufficiency of the Sin3/HDAC corepressor complex member SIN3B causes a syndromic intellectual disability/autism spectrum disorder.
    Latypova X; Vincent M; Mollé A; Adebambo OA; Fourgeux C; Khan TN; Caro A; Rosello M; Orellana C; Niyazov D; Lederer D; Deprez M; Capri Y; Kannu P; Tabet AC; Levy J; Aten E; den Hollander N; Splitt M; Walia J; Immken LL; Stankiewicz P; McWalter K; Suchy S; Louie RJ; Bell S; Stevenson RE; Rousseau J; Willem C; Retiere C; Yang XJ; Campeau PM; Martinez F; Rosenfeld JA; Le Caignec C; Küry S; Mercier S; Moradkhani K; Conrad S; Besnard T; Cogné B; Katsanis N; Bézieau S; Poschmann J; Davis EE; Isidor B
    Am J Hum Genet; 2021 May; 108(5):929-941. PubMed ID: 33811806
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The core FOXG1 syndrome phenotype consists of postnatal microcephaly, severe mental retardation, absent language, dyskinesia, and corpus callosum hypogenesis.
    Kortüm F; Das S; Flindt M; Morris-Rosendahl DJ; Stefanova I; Goldstein A; Horn D; Klopocki E; Kluger G; Martin P; Rauch A; Roumer A; Saitta S; Walsh LE; Wieczorek D; Uyanik G; Kutsche K; Dobyns WB
    J Med Genet; 2011 Jun; 48(6):396-406. PubMed ID: 21441262
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Haploinsufficiency of XPO1 and USP34 by a de novo 230 kb deletion in 2p15, in a patient with mild intellectual disability and cranio-facial dysmorphisms.
    Fannemel M; Barøy T; Holmgren A; Rødningen OK; Haugsand TM; Hansen B; Frengen E; Misceo D
    Eur J Med Genet; 2014 Sep; 57(9):513-9. PubMed ID: 24911659
    [TBL] [Abstract][Full Text] [Related]  

  • 18. WAC loss-of-function mutations cause a recognisable syndrome characterised by dysmorphic features, developmental delay and hypotonia and recapitulate 10p11.23 microdeletion syndrome.
    DeSanto C; D'Aco K; Araujo GC; Shannon N; ; Vernon H; Rahrig A; Monaghan KG; Niu Z; Vitazka P; Dodd J; Tang S; Manwaring L; Martir-Negron A; Schnur RE; Juusola J; Schroeder A; Pan V; Helbig KL; Friedman B; Shinawi M
    J Med Genet; 2015 Nov; 52(11):754-61. PubMed ID: 26264232
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genotype-phenotype evaluation of MED13L defects in the light of a novel truncating and a recurrent missense mutation.
    Asadollahi R; Zweier M; Gogoll L; Schiffmann R; Sticht H; Steindl K; Rauch A
    Eur J Med Genet; 2017 Sep; 60(9):451-464. PubMed ID: 28645799
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MED13L haploinsufficiency syndrome: A de novo frameshift and recurrent intragenic deletions due to parental mosaicism.
    Yamamoto T; Shimojima K; Ondo Y; Shimakawa S; Okamoto N
    Am J Med Genet A; 2017 May; 173(5):1264-1269. PubMed ID: 28371282
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.